Psyence Biomedical (PBM) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $4.22, -2.31% vs the prior close of $4.32.
- Volume 25.63K shares, 0.3x its 50-day average (light).
- New SEC filings: SCHEDULE 13D/A (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
PBM dips 2.3% to $4.22. Closed at $4.22, -2.31% vs the prior close of $4.32. Day range $4.16–$4.53, opened at $4.34.
PBM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — PBM dips 2.3% to $4.22
- Closed at $4.22, -2.31% vs the prior close of $4.32. Day range $4.16–$4.53, opened at $4.34.
- Volume was 25.63K shares, 0.3x its 50-day average of 84.19K — lighter than usual.
- Price is -12.1% vs its 50-day average ($4.80) and -23.6% vs its 200-day average ($5.53).
- 52-week range $1.92–$140.00; today's close sits at 2% of that range, 97.0% below the 52-week high.
Oct 15, 2026 — PBM jumps 4.6% to $4.32
- Closed at $4.32, +4.60% vs the prior close of $4.13. Day range $4.09–$4.44, opened at $4.09.
- Volume was 16.50K shares, 0.2x its 50-day average of 85.09K — lighter than usual.
- Price is -9.7% vs its 50-day average ($4.78) and -23.7% vs its 200-day average ($5.66).
- 52-week range $1.92–$143.52; today's close sits at 2% of that range, 97.0% below the 52-week high.
Oct 14, 2026 — PBM slides 9.2% to $4.13, a 1-month low, 4 down days in a row
- Closed at $4.13, -9.23% vs the prior close of $4.55. Day range $4.10–$4.82, opened at $4.53.
- Volume was 68.20K shares, 0.8x its 50-day average of 84.38K.
- Price is -13.3% vs its 50-day average ($4.76) and -28.9% vs its 200-day average ($5.81).
- 52-week range $1.92–$143.52; today's close sits at 2% of that range, 97.1% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — PBM slides 4.0% to $4.55, a 1-month low, 3 down days in a row
- Closed at $4.55, -4.01% vs the prior close of $4.74. Day range $4.55–$4.79, opened at $4.70.
- Volume was 35.40K shares, 0.4x its 50-day average of 84.29K — lighter than usual.
- Price is -4.1% vs its 50-day average ($4.74) and -23.8% vs its 200-day average ($5.97).
- 52-week range $1.92–$146.09; today's close sits at 2% of that range, 96.9% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — PBM slides 4.6% to $4.74, a 1-month low
- Closed at $4.74, -4.63% vs the prior close of $4.97. Day range $4.73–$5.04, opened at $4.88.
- Volume was 25.30K shares, 0.3x its 50-day average of 85.20K — lighter than usual.
- Price is +0.5% vs its 50-day average ($4.72) and -22.6% vs its 200-day average ($6.12).
- 52-week range $1.92–$150.78; today's close sits at 2% of that range, 96.9% below the 52-week high.
Oct 9, 2026 — PBM dips 2.9% to $4.97
- Closed at $4.97, -2.93% vs the prior close of $5.12. Day range $4.93–$5.20, opened at $5.20.
- Volume was 23.70K shares, 0.3x its 50-day average of 93.68K — lighter than usual.
- Price is +6.1% vs its 50-day average ($4.68) and -20.9% vs its 200-day average ($6.28).
- 52-week range $1.92–$163.28; today's close sits at 2% of that range, 97.0% below the 52-week high.
Oct 8, 2026 — PBM jumps 4.9% to $5.12
- Closed at $5.12, +4.92% vs the prior close of $4.88. Day range $4.86–$5.22, opened at $4.88.
- Volume was 67.10K shares, 0.7x its 50-day average of 92.69K.
- Price is +10.0% vs its 50-day average ($4.65) and -20.4% vs its 200-day average ($6.43).
- 52-week range $1.92–$175.78; today's close sits at 2% of that range, 97.1% below the 52-week high.
Oct 7, 2026 — PBM dips 2.8% to $4.88, 4 down days in a row
- Closed at $4.88, -2.79% vs the prior close of $5.02. Day range $4.84–$5.10, opened at $4.93.
- Volume was 16.90K shares, 0.2x its 50-day average of 93.37K — lighter than usual.
- Price is +5.9% vs its 50-day average ($4.61) and -26.1% vs its 200-day average ($6.60).
- 52-week range $1.92–$175.78; today's close sits at 2% of that range, 97.2% below the 52-week high.
- That makes 4 straight losses.
Oct 6, 2026 — PBM dips 1.2% to $5.02, 3 down days in a row
- Closed at $5.02, -1.18% vs the prior close of $5.08. Day range $4.89–$5.30, opened at $5.08.
- Volume was 50.30K shares, 0.5x its 50-day average of 93.01K — lighter than usual.
- Price is +9.7% vs its 50-day average ($4.58) and -26.9% vs its 200-day average ($6.86).
- 52-week range $1.92–$175.78; today's close sits at 2% of that range, 97.1% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 — PBM dips 1.6% to $5.08
- Closed at $5.08, -1.55% vs the prior close of $5.16. Day range $4.96–$5.56, opened at $5.27.
- Volume was 142.30K shares, 1.6x its 50-day average of 90.99K.
- Price is +12.0% vs its 50-day average ($4.54) and -28.7% vs its 200-day average ($7.13).
- 52-week range $1.92–$175.78; today's close sits at 2% of that range, 97.1% below the 52-week high.
- SEC filings that day: 6-K.
Oct 2, 2026 — PBM slides 5.8% to $5.16
- Closed at $5.16, -5.84% vs the prior close of $5.48. Day range $5.12–$5.63, opened at $5.52.
- Volume was 75.10K shares, 0.8x its 50-day average of 90.75K.
- Price is +14.8% vs its 50-day average ($4.49) and -30.3% vs its 200-day average ($7.40).
- 52-week range $1.92–$175.78; today's close sits at 2% of that range, 97.1% below the 52-week high.
PBM latest news & SEC filings
Every SEC filing by or about PBM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 5, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 5, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 28, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 23, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 26, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 26, 2026 · Form F-3 — F-3 filing
F-3 filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 22, 2026 · Form 20-F — Annual report from a foreign company (20-F)
Annual report from a foreign company (20-F)
Key figures from this report aren't in the SEC's structured data yet (usually appears within a day or two).
Things to know before you trade PBM
- How much it moves: over the last 20 sessions the average daily move was 3.73% (largest 9.2%). That is a volatile stock.
- Liquidity: about 73.29K shares (≈$309.27K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $4.22 vs a range of $1.92–$140.00 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 16:100 on Feb 2, 2026, 16:100 on Jan 20, 2026, 125:1000 on May 5, 2025, 1:75 on Nov 26, 2024
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 5, 2026; 6-K Sep 28, 2026; 6-K Sep 23, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
PBM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 4.34 | 4.53 | 4.16 | 4.22 | 25.63K |
| Oct 15, 2026 | 4.09 | 4.44 | 4.09 | 4.32 | 16.50K |
| Oct 14, 2026 | 4.53 | 4.82 | 4.10 | 4.13 | 68.20K |
| Oct 13, 2026 | 4.70 | 4.79 | 4.55 | 4.55 | 35.40K |
| Oct 12, 2026 | 4.88 | 5.04 | 4.73 | 4.74 | 25.30K |
| Oct 9, 2026 | 5.20 | 5.20 | 4.93 | 4.97 | 23.70K |
| Oct 8, 2026 | 4.88 | 5.22 | 4.86 | 5.12 | 67.10K |
| Oct 7, 2026 | 4.93 | 5.10 | 4.84 | 4.88 | 16.90K |
| Oct 6, 2026 | 5.08 | 5.30 | 4.89 | 5.02 | 50.30K |
| Oct 5, 2026 | 5.27 | 5.56 | 4.96 | 5.08 | 142.30K |
| Oct 2, 2026 | 5.52 | 5.63 | 5.12 | 5.16 | 75.10K |
| Oct 1, 2026 | 5.42 | 5.70 | 5.40 | 5.48 | 14.90K |
| Sep 30, 2026 | 5.43 | 5.72 | 5.38 | 5.46 | 17.80K |
| Sep 29, 2026 | 5.68 | 5.73 | 5.41 | 5.43 | 27.70K |
| Sep 28, 2026 | 5.59 | 5.82 | 5.51 | 5.66 | 48.30K |
| Sep 25, 2026 | 5.81 | 5.96 | 5.41 | 5.56 | 110.50K |
| Sep 24, 2026 | 6.19 | 6.37 | 5.61 | 5.86 | 137.50K |
| Sep 23, 2026 | 5.87 | 7.18 | 5.87 | 6.31 | 293.90K |
| Sep 22, 2026 | 6.50 | 6.50 | 5.85 | 6.10 | 179.20K |
| Sep 21, 2026 | 6.64 | 6.90 | 6.50 | 6.52 | 89.50K |
About Psyence Biomedical
Psyence Biomedical (PBM) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in TORONTO. State of incorporation: Ontario, Canada. Fiscal year ends March 31. SEC CIK 1985062.
PBM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
PBM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
PBM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on PBM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.